Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Topical Pain Relief Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Topical Pain Relief Market Business Segmentation
2.5 Topical Pain Relief Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Topical Pain Relief Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Topical Pain Relief Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Topical Pain Relief Market has been analysed to include the below segmentation:
By Therapeutic Class
• Non-opioids
• Opioids
By Type
• Prescription Pain Relief
• Over-the-counter (OTC) Pain Relief
By Formulation
• Cream
• Gel
• Spray
• Patch
• Others
By Distribution Channel
• Pharmacy & Drug Store
• e-Commerce
• Retail & Grocery Store
Chapter 5A. Regional Segmentation
The Topical Pain Relief Market has been analysed by studying the following regions:
North America
• By Therapeutic Class
• By Type
• By Formulation
• By Distribution Channel
Europe
• By Therapeutic Class
• By Type
• By Formulation
• By Distribution Channel
APAC
• By Therapeutic Class
• By Type
• By Formulation
• By Distribution Channel
LatAm
• By Therapeutic Class
• By Type
• By Formulation
• By Distribution Channel
MEA
• By Therapeutic Class
• By Type
• By Formulation
• By Distribution Channel
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Topical Pain Relief Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Topical Pain Relief Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Topical Pain Relief Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• AdvaCare Pharma
• GlaxoSmithKline plc (GSK)
• Johnson & Johnson
• Nestl• S.A.
• Novartis AG
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Topical BioMedics, Inc.
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us